Pharmacy Curriculum Outcomes Assessment (PCOA) Practice Exam

Zanamivir (Relenza) is an antiviral medication that is used to treat uncomplicated influenza A and B. It is not indicated for the treatment of tuberculosis, hepatitis B or the common cold. Tuberculosis is a bacterial infection and is usually treated with antibiotics. Hepatitis B is a viral infection and has its own specific treatment options. The common cold is caused by a virus and does not have a specific treatment, usually just managing symptoms is recommended. Zanamivir specifically targets and inhibits the influenza virus, making it an effective treatment for this specific illness.